US Patent 8946388 Monoclonal antibodies for treatment of cancer
Patent 8946388 was granted and assigned to Ganymed Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8946388 Monoclonal antibodies for treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.